USPTO serial 87888540
CONSTELLATION
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CONSTELLATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of cancer, inflammatory, and fibrotic disorders; pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceutical preparations for the treatment of lymphomia, solid cancers, blood disease, myelofibrosis, Alzheimer's disease, arthritis, Sjogren's syndrome, autoimmune hepatitis, systemic lupus erythematosus, venus thromboembolism (VTE), cancer associated thrombosis (CAT), renal autoimmune disease, pulmonary sarcoidosis, severe atopic dermatitis, diabetes, asthma, chronic obstructive pulmonary disease (COPD) | ACTIVE | — |
| 042 | Pharmaceutical research and development; Research and development in the fields of genetics, pharmaceuticals, cancer, epigenetics, and immune-oncology, all of the foregoing for the purposes of drug development; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Constellation Pharmaceuticals, Inc.
- Other trademarks owned by Constellation Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CONSTELLATION
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 15, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 9, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 9, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 5, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 5, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 5, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 7, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 6, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 6, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 6, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 7, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 7, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 7, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 10, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 8, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 8, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 8, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 8, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 12, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 13, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 13, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 24, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 10, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 10, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 10, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 3, 2022 | DMCC | DATA MODIFICATION COMPLETED | — |
| Aug 3, 2022 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 5, 2022 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 5, 2022 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 5, 2022 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jun 15, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 20, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 12, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 7, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 6, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 6, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 6, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 30, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 30, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 30, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 30, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 31, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 31, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 31, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 13, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 26, 2018 | NWAP | NEW APPLICATION ENTERED | — |